Treatment for Neurodegenerative Diseases

Promoting Neuronal Regeneration 

The Discovery

UNSW researchers have identified a novel role for leukocyte immunoglobulin-like receptor (LILR) molecules which act to promote neuronal regeneration. This has the potential to treat a wide range of neurodegenerative diseases

Key Benefits

• Naturally-occurring molecules to use as therapeutic intervention

• Demonstrated efficacy in vitro

Applications

• Multiple Sclerosis

• Alzheimer’s Disease

• Parkinson’s Disease

• Amyotrophic Lateral Sclerosis

• Motor Neuron Disease

• Muscular Dystrophy

• Huntington’s Disease

• Spinal cord regeneration

The Opportunity

NewSouth Innovations has recently filed an Australian provisional patent around the technology and is actively seeking development and/or exclusive licensing partners.

Please click here to view a one-page Technology Brief